Background-Although right ventricular (RV) dysfunction is a major determinant of outcome in patients with pulmonary hypertension (PH), the optimal measure of RV function is poorly defined. We hypothesized that RV strain measured by speckle-tracking echocardiography predicts outcome in PH over a broad range of pulmonary pressures. Methods and Results-Prospective peak RV longitudinal systolic strain measurement was performed on 575 patients (mean age, 56±18 years; 63% women) referred for echocardiography for known or suspected PH. Survival status was assessed over a median of 16.5 (interquartile range, 7.6-20.0) months. There were 406 patients with PH (71%) (74% group 1, 14% group 3, and 12% group 4) and 169 patients without evidence of PH (29%). Among patients with PH, 46% were World Health Organization functional class III-IV. The mean RV strain was −21.2±6.7% for all patients. RV strain declined with worse functional class, shorter 6-minute walk distances, higher N-terminal pro-B-type natriuretic peptide levels, and the presence of right heart failure. RV strain predicted outcome across pulmonary pressures and groups of PH. Eighteenmonth survival was 92%, 88%, 85%, and 71% according to RV strain quartile (P<0.001), with a 1.46 higher risk of death (95% confidence interval, 1.05-2.12) per 6.7% decline in RV strain. RV strain predicted survival when adjusted for pulmonary pressure, pulmonary vascular resistance, and right atrial pressure and provided incremental prognostic value over conventional clinical and echocardiographic variables. Conclusions-Quantitative assessment of RV free-wall systolic strain is feasible and is a powerful predictor of the clinical outcome of patients with known or suspected PH. (Circ Cardiovasc Imaging. 2013;6:711-721.) The online-only Data Supplement is available at http://circimaging.ahajournals.org/lookup/suppl/
R ight ventricular (RV) function is a major determinant of prognosis among patients with pulmonary hypertension (PH), 1 with the onset of RV failure associated with marked mortality risk among patients with PH, irrespective of etiology. [2] [3] [4] [5] An accurate, feasible, and reproducible noninvasive assessment of RV function is warranted for the initial and serial evaluation of patients with known or suspected PH. Despite this, the best noninvasive measures of RV function remain uncertain.
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Transthoracic echocardiography represents one of the most widely available noninvasive tools for the evaluation of PH. 6, 7 Although volumetric assessment of RV function by echocardiography may be challenging (due to the complex and asymmetrical chamber geometry of the RV), 8 nonvolumetric parameters have demonstrated feasibility and are of prognostic importance in PH. 1, [9] [10] [11] [12] [13] However, many of these parameters represent only a small area of myocardial contractility and can be prone to error through translational cardiac motion. Frequently, these methods fail to provide prognostic information across a broad range of pathology. These challenges highlight the need for improved methods of RV functional assessment in PH.
The measurement of myocardial contractility by 2-dimensional (2D) speckle-tracking strain echocardiography has been demonstrated to be a feasible and sensitive quantitative technique for assessing left ventricular (LV) contractile function for a variety of different cardiac diseases. Preliminary studies have demonstrated that measurement of RV longitudinal systolic strain using speckle-tracking echocardiography may be a valid method to assess RV function in PH. [14] [15] [16] [17] [18] However, these studies are retrospective in design with limited numbers of patients with PH. In addition, there is a lack of data regarding the prognostic importance of RV strain in PH across ranges of pulmonary pressure and disease severity. The purposes of this study were, in a consecutive population of patients referred for evaluation of known or suspected PH, to prospectively 1) determine the feasibility of performing RV strain analysis using speckle-tracking echocardiography, 2) characterize the pattern and severity of RV strain abnormalities in patients with PH, and 3) establish the prognostic use of RV strain measurement for patients with PH across degrees of ventricular load.
Methods

Study Population
Consecutive patients referred for transthoracic echocardiography evaluation of known or suspected PH between October 2010 and July 2011 were included. A total of 678 patients underwent comprehensive transthoracic echocardiography with inclusion of RV longitudinal peak systolic strain measurement by speckle-tracking echocardiography as part of the clinical protocol for PH evaluation at the Mayo Clinic Echocardiography Laboratory (Rochester, MN) during the study period ( Figure 1 ). This protocol, which included a focused assessment of pulmonary artery (PA) hemodynamics and right-sided structure and function, was performed in patients with known or suspected group 1, 3, or 4 PH. Due to fundamental differences on RV pulsatile afterload in postcapillary PH, patients with established or suspected group 2 PH (pulmonary venous hypertension) were not included. 19 There were 79 patients (11.7%) excluded due to 2D image quality that was inadequate for RV strain analysis. A subsequent 24 patients (3%), who were later established to have group 2 PH on the basis of right heart catheterization (RHC), were excluded for a final study cohort of 575 patients ( Figure 1 ). Patients were then categorized as either having PH or not based on the following criteria: an established prior PH diagnosis, mean PA pressure ≥25 mm Hg measured during RHC, or PA systolic pressure ≥50 mm Hg estimated by echocardiography for patients who did not undergo RHC. Patients with PH were further categorized into group 1 (pulmonary arterial hypertension), group 3 (PH due to lung diseases and/or hypoxia), or group 4 (chronic thromboembolic PH) according to the Dana Point PH classification criteria. 20 All patients consented to the use of their medical data for research purposes. This study was approved by the Mayo Clinic Institutional Review Board.
Echocardiographic Measurements
Complete 2D and Doppler echocardiograms were performed with commercially available echocardiography systems equipped with a 3.5 MHz transducer (Vivid 7 or E9; General Electric Healthcare, Milwaukee, WI), according to American Society of Echocardiography guidelines. 8, 21 Quantitative data were obtained and stored in a database and not altered throughout the study. Tricuspid annular plane systolic excursion (TAPSE) was measured by placing an M-mode cursor through the lateral tricuspid valve annulus in the apical 4-chamber view and measuring the total systolic excursion distance of the tricuspid annulus. Peak systolic velocity of the lateral tricuspid valve annulus was measured by tissue Doppler imaging. RV fractional area change was calculated as follows: (end-diastolic area − the end-systolic area)/enddiastolic area × 100. Right atrial (RA) pressure estimation was based on interrogation of the inferior vena cava (IVC) diameter and distensibility and pulsed-wave Doppler interrogation of the hepatic vein flow, and it was scored as 5 (normal sized IVC with >50% respiratory collapse and systolic forward predominant flow on hepatic vein Doppler), 10 (borderline/normal sized IVC with >50% respiratory collapse and equal degrees of systolic and diastolic forward flow on hepatic vein Doppler), 15 (enlarged IVC with >25% respiratory collapse and predominant diastolic forward flow on hepatic vein Doppler), or 20 mm Hg (enlarged IVC with minimal or no collapse and solely diastolic forward flow or systolic flow reversal on hepatic vein Doppler) according to the Mayo Clinic protocol. 22 PA systolic pressure was estimated from the peak continuous-wave Doppler velocity of tricuspid valve regurgitation plus the estimated RA pressure. No patient had 2D or Doppler evidence of pulmonary valve stenosis or RV outflow tract obstruction. Tricuspid valve regurgitation was qualitatively graded using color-flow Doppler according to American Society of Echocardiography guidelines as follows: normal/trivial, mild, moderate, or severe. 23 Diastolic PA pressure was estimated from the end-diastolic continuous-wave Doppler velocity of the pulmonary valve regurgitation signal plus the estimated RA pressure. The RV index of myocardial performance (Tei index) was calculated as the sum of isovolumic contraction and relaxation times divided by the RV outflow ejection time. 11 RV outflow tract time-velocity integral was measured using pulsed-wave Doppler, and PA capacitance was calculated as the Doppler-derived stroke volume divided by the PA pulse pressure. 12
RV Strain Analysis by Speckle-tracking Echocardiography
Using speckle-tracking echocardiography analysis, peak longitudinal systolic strain of the RV free wall was measured from an RV-focused apical 4-chamber view with the RV positioned centrally in the imaging sector. Frame rate was optimized to >40 frames/s by narrowing the imaging sector and reducing depth to focus on the RV. Three cardiac cycles were recorded. Speckle-tracking echocardiography allows for relatively angle-independent evaluation of strain by tracking frame-to-frame movement of acoustic markers (speckles) within a myocardial region of interest on 2D grayscale images. 24 Longitudinal strain is defined as the percentage shortening of a region of interest relative to its original length and is expressed as a negative percentage. 25 The measurements were performed online using dedicated software (Automated Functional Imaging; GE Healthcare). A region of interest was traced by placing points along the RV endocardial border and adjusting the thickness of the myocardium accordingly. The Automated Functional Imaging software then uses a tracking algorithm to trace endocardial and epicardial contours throughout the cardiac cycle, which can be manually adjusted to the RV myocardium to ensure adequate tracking. The RV free wall is automatically divided into basal, middle, and apical segments. Peak longitudinal systolic strain was obtained for each segment from software-generated strain curves and averaged for a mean RV free-wall strain value. Strain measurements of the interventricular septum were not recorded.
Statistical Analysis
Data are expressed as the mean±SD or median±interquartile range for continuous variables and as frequency and percentage for categorical variables. Comparisons between groups were based on 2-sided t tests for continuous variables and Pearson χ 2 test for categorical variables. Comparison of strain values across different RV free-wall segments was performed using analysis of variance with repeated measures design. Correlation between echocardiographic measures of RV systolic function was evaluated using Pearson correlation coefficient (r). To exclude significant effects of multicollinearity between measures of RV function in the regression models, the variance inflation factors were evaluated. No 2 measures of RV function met the predetermined variance inflation factor thresholds of ≥5, suggesting no significant collinearity of the variables. RV strain quartiles were determined from the distribution of average values for RV free-wall strain from those patients with PH as follows: group 1, ≤ −25%; group 2, −20 to −24%; group 3, −15 to −20%; group 4, > −15%. The primary end point was a) death from all causes. Secondary end points included b) cardiopulmonary death and c) cardiopulmonary events (cardiopulmonary death, lung transplant, atrial septostomy and PH-related hospitalization). The need for new or uptitration of PH medical therapy was included as a secondary end point for select analyses. Only patients categorized as having PH according to the study criteria were evaluated for secondary study end points. Patients lost to follow-up were censored at the time of last available follow-up. Kaplan-Meier survival curves were constructed, and the log-rank test was used for comparison between groups. For time to event analyses, event time was calculated as time from RV strain analysis to death for patients known to be deceased. Multivariate Cox proportional hazards stepwise inclusion/exclusion regression modeling (with a probability value threshold of ≤0.1) was used to identify variables associated with study end points. Clinical variables selected for this analysis were age, sex, World Health Organization (WHO) functional class, 6-minute walk distance, PH disease duration, number of PH-specific medical therapies, log N-terminal pro-B-type natriuretic peptide, evidence of right heart failure on physical examination (defined as the presence of jugular venous distension, peripheral edema, and/or ascites), and echocardiographic variables, including estimated RA pressure, RV index of myocardial performance, TAPSE, peak systolic velocity of the lateral tricuspid valve annulus measured using tissue Doppler imaging, the time-velocity integral of the RV outflow tract flow as measured using Doppler imaging, estimated PA systolic pressure, pericardial effusion, RV fractional area change, PA capacitance, cardiac index, and peak systolic longitudinal RV free-wall strain. Age and sex were forced into the multivariate model. Incremental models were constructed using these clinical variables first, then conventional echocardiographic variables were added, followed by RV strain. The survival c statistic was calculated to show the discriminatory ability of the models. 26 In order to assess the prognostic abilities of the incremental models, the integrated discrimination improvement (IDI) measure was calculated at 18-month follow-up. The IDI measures the change in the differences of the mean predicted probabilities of an event between subjects with and without an event. 27 All probability values were 2-sided, and a value of ≤0.05 was considered statistically significant. Statistical analyses were performed using JMP software version 9.0 and SAS software version 9.2 (SAS Institute, Inc, Cary, NC).
Results
Clinical Characteristics
Clinical and laboratory characteristics are presented in Table 1 . Among the 575 patients studied, 406 patients (71%) had PH and 169 patients (29%) did not based on predefined study criteria. Patients with PH were significantly older, had a higher body mass index, required supplemental oxygen more often, had more evidence of clinical right heart failure, used more diuretics, had higher N-terminal pro-B-type natriuretic peptide levels, and had lower diffusion capacity than those without PH. Among the 406 patients with PH, 298 patients (77%) had a pre-existing diagnosis of PH and 108 patients (23%) were newly diagnosed around the time of RV strain analysis. Of those with a pre-existing diagnosis of PH, the mean disease duration was 4.8±3.7 years. Of those with a new PH diagnosis, 55 patients (51%) were diagnosed using invasive RHC criteria and 53 patients (49%) were diagnosed using echocardiographic criteria. Of the 406 patients with PH, 300 patients (74%) had group 1, 58 patients (14%) group 3, and 48 patients (12%) group 4 PH by Dana Point classification criteria ( Figure 1 ). There were 80 patients (20%) who were WHO functional class I, 138 patients (34%) class II, 154 patients (38%) class III, and 34 patients (8%) class IV. The mean 6-minute walk distance for patients with PH was 363±131 m, and 99 patients (24%) demonstrated evidence of clinical right heart failure. Of the 146 patients with established group 1 PH, 50 patients (34%) were on a prostacyclin analog at the time of echocardiography, including 32 (22%) parenteral, 14 (10%) inhaled, 3 (2%) subcutaneous, and 1 (<1%) oral therapy. There were 82 patients (56%) taking an endothelin receptor antagonist and 89 patients (61%) a phosphodiesterase-5 inhibitor.
Among patients with PH, 84 patients (21%) underwent RHC within 1 week of RV strain analysis. The mean RA pressure was 11±6 mm Hg, systolic/diastolic PA pressure 78±19/31±11 mm Hg, mean PA pressure 54±13 mm Hg, mixed venous oxygen saturation 61±12%, cardiac index 2.5±1.0 L/min/m 2 , and pulmonary vascular resistance index 18±9 Wood units/m 2 . The majority of these patients (n=77, 92%) underwent acute vasodilatory testing during RHC, with a positive vasodilator response in 15 (20%), defined as a decrease in mean PA pressure of ≥10 mm Hg to a level of ≤40 mm Hg without a concomitant decrease in cardiac output. 28 At physician discretion, 7 patients (8%) did not undergo vasodilatory testing due to advanced and/or WHO functional class IV disease.
Echocardiographic Characteristics
Echocardiographic characteristics for the study population and patients with and without PH are presented in Table 2 . RV dimensions were significantly enlarged in patients with PH compared with those without, and measures of RV systolic function, including fractional area change, RV index of myocardial performance, and TAPSE, were significantly impaired in patients with PH. Tricuspid valve regurgitation was absent to mild in 261 (64%) patients with and 160 (95%) without PH and ≥moderate in 83 (20%) and 4 (2%) patients with and without PH, respectively (P<0.001). The estimated PA systolic pressure was 59±23 and 29±5 mm Hg among patients with and without PH (P<0.001) and was not measurable by 
RV Strain Characteristics
Mean RV free-wall and segmental peak longitudinal systolic strain values and distribution curves for patients with and without PH are presented in Figure 2 . The mean RV strain was −21.2±6.7% for all patients and −19.6±6.6% and −25.0±5.2% for those with and without PH (P<0.001). Segmental RV strain values were significantly worse (less negative) for patients with PH compared with those without PH (P<0.001 for all). There was a significant difference in strain values across all RV free-wall segments for the study population and patients with and without PH (P<0.001, P=0.019, and P<0.001, respectively). Patients with clinical right heart failure had lower RV strain (−16±6%) than those without (−22±6%, P<0.005).
PH patients were grouped according to RV strain quartiles as follows: group 1, best RV strain, n=188; group 2, n=176; group 3, n=113; and group 4, worst RV strain, n=98. Clinical markers of PH disease severity and echocardiographic measures of RV function and right heart hemodynamics across RV strain quartiles are presented in Table 3 . Both clinical and echocardiographic parameters demonstrated a graded and significant decline with worsening RV strain quartile.
Outcomes and Predictors
The median follow-up period for the study population with and without PH, respectively (P=0.31). Fifteen patients (2.6%) were lost to follow-up with data censored at the time of last available follow-up. During the follow-up period, 48 patients (8%) died, including 6 patients who died of cancer. Among noncancer deaths, 31 (74%) were due to complications of PH, 6 (15%) end-stage chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis, 3 (7%) end-stage renal disease, 1 (2%) liver transplant rejection, and 1 (2%) cerebral aneurysm rupture. There were 40 (10%) noncancer deaths among patients with PH and 2 (1%) among patients without PH, both due to end-stage renal disease. Four PH patients (<1%) underwent lung transplant and 1 patient underwent atrial septostomy. There were an additional 28 (7%) PH-related hospitalizations among patients with PH during the follow-up period, including 19 (68%) for treatment of right heart failure and 9 (32%) for acute dyspnea. Eightythree patients (20%) had their PH medical therapy intensified, including 29 patients (7%) who were initiated on a prostacyclin analog, 23 patients (6%) an endothelin receptor antagonist, 17 patients (4%) a phosphodiesterase-5 inhibitor, and 14 patients (3%) whose existing PH medical therapy dose was uptitrated. The median time to intensification of PH medical therapy was 5.9 (interquartile range, 2.6-13.2) months. Survival after 18-month follow-up was lower among patients with PH (82%) than patients without PH (96%). Survival of the study population stratified by RV strain quartile is presented in Figure 3 . Worsening RV strain quartile was associated with an increased risk of all-cause death ( Figure 3A ) and a shorter time free of cardiopulmonary death ( Figure 3B) , especially for patients with moderate or severely impaired RV strain. Among patients with PH, the occurrence of cardiac events including PH-related hospitalization ( Figure 4A ) and the need for intensified PH medical therapy ( Figure 4B ) were more frequent in those patients with worse RV strain. When analyzed separately based on Dana Point classification group, RV strain predicted cardiopulmonary outcomes in all groups ( Figure I in the online-only Data Supplement). The sensitivities of an abnormal TAPSE and RV strain to predict outcome were also compared. Using a cutoff value of <18 mm, 9 TAPSE had a sensitivity of 61% to predict the primary end point of allcause mortality, 59% for the secondary end point of cardiopulmonary death, and 50% for the secondary study end point of cardiopulmonary death, lung transplant, atrial septostomy, or PH-related hospitalization. By comparison, using an RV strain cutoff of >-25%, sensitivities to predict these outcomes were superior at 79%, 89%, and 78%, respectively.
Age and sex adjusted analysis of the study population demonstrated that RV strain predicted the primary study end point of all-cause mortality independent of other clinical or echocardiographic variables (hazard ratio, 1.46; 95% confidence interval [CI], 1.05-2.12; P<0.001) ( Table 4 ). Other independent predictors were WHO functional class, log N-terminal pro-Btype natriuretic peptide, and the presence of pericardial effusion. The c statistic for the clinical model was c=0.73 (95% CI, 0.69-0.75) and addition of echocardiographic variables added borderline prognostic information (c=0.75; 95% CI, 0.71-0.77; P=0.069) with a gain in IDI of 0.024 (P=0.04). The addition of RV strain to the model increased the c statistic significantly (c=0.79; 95% CI, 0.78-0.82; P<0.001) with a greater gain in IDI of 0.101 (P=0.009). RV strain was also the only independent echocardiographic predictor of the secondary study end point of cardiopulmonary death, lung transplant, atrial septostomy, or PH-related hospitalization (hazard ratio, 1.27; 95% CI, 1.04-1.56; P<0.001) among patients with PH (Table 5 ). WHO Table 5 ). The c statistic for the clinical model was c=0.75 (95% CI, 0.71-0.78) and addition of echocardiographic variables added no significant prognostic information (c=0.76; 95% CI, 0.71-0.79; P=0.148) with a gain in IDI of 0.018 (P=0.103). The addition of RV strain to the model increased the c statistic significantly (c=0.81; 95% CI, 0.80-0.84; P<0.001) with a significant gain in IDI of 0.112 (P<0.001).
Discussion
This study demonstrates the use of quantifying RV function by peak longitudinal systolic strain measurement routinely in patients referred for echocardiographic evaluation for known or suspected PH. In a large cohort of consecutive patients, RV strain analysis was feasible in 88% when measured online as part of a regularly performed PH-specific protocol during clinically indicated echocardiogram. The key finding is that this feasible quantitative grading of RV function by speckletracking strain echocardiography is a powerful predictor of the clinical outcome of patients with known or suspected PH, especially for patients with the greatest degree of RV strain impairment. The prognostic power of this strain-based assessment superseded other echocardiographic measures and was incremental to clinical status.
PH is a life-threatening disease characterized by pulmonary vascular remodeling and right heart failure. 3, 29 RV function is one of the most important determinants of outcome in patients with PH. 2, 3 Although RHC is considered the gold standard for right heart hemodynamic evaluation, frequent or serial invasive testing is not practical for many patients and centers. Cardiovascular MRI has developed into a valuable noninvasive method to assess RV size and function; however, availability and cost remain relative limitations, and there is very little prognostic data of RV ejection fraction by cardiovascular MRI in patients with PH. 27, 30, 31 Transthoracic echocardiography has been one of the most frequently used tests for the initial and serial evaluation of patient with known or suspected PH. Although many echocardiographic parameters have been studied to evaluate PH, few have consistently demonstrated reproducibility and prognostic use to date. TAPSE is one such parameter that is commonly used for noninvasive PH risk stratification. 9,10 However, TAPSE only measures tricuspid annular motion, and may not accurately reflect RV global or segmental contractile function, and like many other parameters may be subject to error secondary to translational cardiac motion, a limitation not shared by speckle-tracking-based strain imaging.
Measurement of myocardial strain using speckle-tracking echocardiography offers quantitative evaluation of ventricular systolic function and has demonstrated feasibility and prognostic significance for different populations of patients with LV dysfunction. 32 Strain imaging is sensitive to early impairments in systolic function that may develop despite the presence of normal appearing contractility by 2D imaging. This makes strain potentially valuable for assessment of the RV, including early disease. Longitudinal systolic strain measurement is also especially well suited to assess RV function because RV contractility predominantly occurs in the longitudinal plane due to the principal orientation of myocardial fibers. 33 Previous studies have demonstrated feasibility for measuring RV strain using speckle-tracking echocardiography in PH 34, 35 and other causes of RV dysfunction. [36] [37] [38] [39] However, these studies included limited numbers of patients with PH. Fukuda et al 15 performed RV strain analysis in 45 patients with PH and 22 healthy control subjects. RV strain values were reduced in patients with PH and were similar to values reported in our study. RV strain measurement correlated with 6-minute walk distance, RV ejection fraction, and endsystolic volume as measured by cardiovascular MRI and elevated mean PA pressure and pulmonary vascular resistance by RHC. RV strain also improved on follow-up evaluation in patients whose 6-minute walk distance increased after starting PH medical therapy, suggesting a potential role for serial RV strain evaluation for assessing response to therapy. Tissue Doppler imaging-based strain analysis has been previously found to detect abnormalities in regional RV function in PH. 40, 41 However, this method is more technically challenging than speckle-tracking echocardiography measured strain because it is highly angle dependent and requires higher frame rates. 32 RV strain measured using velocity vector imaging, a type of speckle-tracking echocardiography software that allows retrospective measurement of myocardial strain from images archived in Digital Imaging and Communications in Medicine format, has also been shown to be impaired in patients with PH, and it correlates well with clinical and echocardiographic markers of disease severity. 16, 42 Recently, Haeck et al 17 illustrated the versatility of RV strain by speckle-tracking echocardiography analysis performed using images acquired from a subcostal window, demonstrating feasibility and good correlation with the standard apical 4-chamber view.
We previously demonstrated that RV strain independently predicted clinical disease progression and mortality. 16 However, this report was limited by its retrospective design, small sample size (n=80), and predominantly advanced stages of disease. In this prior analysis, we found that the RV free-wall strain had best prediction, and hence, we choose to measure only the free-wall strain rather than including the septum, which reflects both RV and LV contractility. Inclusion of interventricular septum strain as a component of global RV strain varies among prior studies for both PH and other right heart diseases, and currently, there is no consensus on the best approach. Our approach simplifies the analysis process to focus on tracking of the RV free-wall segments, reducing analysis time when performed online routinely as part of a clinically indicated comprehensive echocardiogram. Focusing on the RV free wall provides an assessment of the predominant wall contributing to RV contractile function while maintaining an analysis that is easy and feasible in clinical practice.
Although PH is characterized by an elevation in PA pressure, there are fundamental differences between the various PH groups and their pathobiology with respect to pulmonary vascular disease. The focus of this study was RV adaptation to increases in afterload and how RV strain analysis may characterize this adaptation and predict outcome. We chose to include forms of PH characterized by elevated pulmonary vascular resistance secondary to precapillary forms of PH and exclude those with pulmonary venous hypertension. Highlighted in a recent study, 19 pulmonary vascular resistance and compliance demonstrate a highly predictable inverse relationship of loading on the RV which is similar across different forms of precapillary PH, including groups 1 and 3. However, this relationship is altered significantly by elevations in pulmonary capillary wedge pressures. Elevated pulmonary capillary wedge pressure, as occurs in group 2 PH, lowers pulmonary vascular compliance for any given resistance, augmenting RV pulsatile afterload. It was for these reasons we included group 3 but excluded group 2 PH patients. Although RV strain may have a prognostic role in assessing RV function in patients with left heart disease and represents an important area for further research, the data in this manuscript cannot be applied to this group of patients.
Limitations
Ours was a single-center study performed at a large PH referral center, so referral bias cannot be excluded. Patients with a broad range of PH disease severity and etiology were included, and so the results are likely generalizable to a broader PH patient population. Despite a relatively short follow-up period, the prognostic use of RV strain was still demonstrated. Our study aimed to assess the feasibility of routine online RV strain analysis as part of a comprehensive clinically indicated echocardiogram in patients referred for evaluation of PH and did not incorporate a direct assessment of reproducibility. In a similar cohort with identical technology, we have recently demonstrated that RV free-wall strain is reproducible with excellent levels of agreement for clinically relevant thresholds. 43 Previous studies have also demonstrated very good reproducibility for RV strain analysis in PH. 14, 17, 37 RV strain measurement was not done simultaneously with RHC, and so correlation with invasive right heart hemodynamics could not be analyzed. All RV strain analysis software, including that used in this study, were designed primarily for LV strain analysis and adapted for use on the RV. RV-specific strain analysis software has yet to be developed, and if developed, it may be even better suited for this purpose than the current analysis platforms. In addition to longitudinal systolic strain, speckle-tracking echocardiography is capable of measuring strain in the radial and circumferential vectors of myocardial contraction from short-axis imaging windows, and these strain vectors have been extensively studied in various diseases affecting the LV. Less is known about their importance and relative contribution to RV performance and prognosis, although recent cardiovascular MRI data suggest that transverse RV function may be an important contributor of right-heart performance in late stages of disease. 44 Currently, there are no commercially available clinical echocardiography systems that allow online assessment of RV radial and/or circumferential strain measurement, and hence, this was beyond the scope of our study.
Conclusions
Prospective online measurement of RV strain is feasible when performed routinely as part of a clinically indicated echocardiographic evaluation for known or suspected PH. RV strain correlated well with multiple clinical and other echocardiographic measures of PH disease severity. RV strain was of prognostic significance among patients with PH and predicted clinically relevant outcomes, adding incremental prognostic information to established clinical and echocardiographic markers. RV strain can be successfully incorporated into a comprehensive echocardiographic PH clinical protocol and may represent a valuable noninvasive method of evaluation that could be widely adopted among PH centers.
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